Harmony Biosciences Holdings Inc

HRMYNASDAQ · USD
32.59USD0.00 (-1.19%)
967

Harmony Biosciences Holdings Inc (HRMY) Option Chain

Harmony Biosciences Holdings Inc trades at $32.59, down 1.19%, with an IV Rank of 36.51%. This is average versus the past year, and the company carries a market cap of $1,914M in the Biotechnology industry. On the Dec 18, 2026 chain, the at the money $32.50 strike shows calls at $0.50 / $4.60 and puts at $0.15 / $3.30, both carrying about $2.09 of extrinsic value. The call has a 51.94% probability of expiring out of the money, and the put has 48.06%. Volume is heaviest on the $40.00 calls, at 1 contracts, and the $35.00 puts, at 11, as of Nov 20, 2026.

Read more

Tracking the HRMY option chain helps you see every strike and expiry on Harmony Biosciences Holdings Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HRMY options activity at a glance. Use our scanner to monitor the HRMY option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HRMY stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where HRMY options are being actively traded, and where they are not.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
17.183801.065.094.308.0027.50-15.620.351.200.000.7805,68482.82
33.421801.482.592.156.0030.00-7.950.853.100.001.98045666.58
51.94802.460.090.504.6032.50-0.280.153.300.001.73089548.06
68.806403.300.00—3.3035.00+7.391.604.802.410.79114,00431.20
81.6313003.800.00—3.8037.50+15.073.507.304.910.49011618.37

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank36.51% Moderate
  • Market cap (M$)1,914
  • 52 weeks high-25.06%
  • 52 weeks low25.83%
  • Analyst recommendationBuy
    1.75
  • Target price$48.08
    47.53% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-04
  • P/E10.77
  • Future P/E8.26
  • EPS (ttm)3.03
  • EPS growth next 5 years18.41%

As of Nov 20, 2026